Unichem Laboratories Limited (UNICHEMLAB.NS) NSE
366.00
+22.95(+6.69%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
366.00
+22.95(+6.69%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2875
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Scott Delaney | President & Chief Executive Officer of Unichem Pharmaceuticals (USA), Inc. | 0 | 1969 |
| Vinod Kumar Behl | Head of Projects & Investments | 2.1M | 1950 |
| Sanjay Jain | Chief Financial Officer | 5.6M | 1978 |
| Pradeep Kumar Bhandari | Head of Legal, Company Secretary & Compliance Officer | 10.7M | 1958 |
| Pabitrakumar Kalipada Bhattacharyya | MD & Director | 30.7M | 1969 |
| Bhagwat S. Dhingra | Chief Executive of Domestic Pharma | 0 | 1963 |
| Jalesh Burye | Chief Quality & Compliance Officer | 0 | N/A |
| Prasad Joshi | Vice President of Human Resources & ER | 0 | 1958 |
| Utkarsh Patil | Chief Manufacturing Officer of Formulations | 0 | N/A |
| Dhananjay Sathe | Chief Scientific & Compliance Officer | 0 | N/A |
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.